NYSEAMERICAN:YCBD cbdMD (YCBD) Stock Price, News & Analysis $0.92 -0.01 (-1.11%) Closing price 05/23/2025 04:10 PM EasternExtended Trading$0.91 -0.01 (-0.95%) As of 05/23/2025 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesSEC FilingsShort InterestBuy This Stock About cbdMD Stock (NYSEAMERICAN:YCBD) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get cbdMD alerts:Sign Up Key Stats Today's Range$0.89▼$0.9350-Day Range$0.86▼$2.6652-Week Range$0.76▼$6.54Volume38,123 shsAverage Volume97,250 shsMarket Capitalization$5.76 millionP/E RatioN/ADividend YieldN/APrice Target$3.00Consensus RatingBuy Company OverviewcbdMD, Inc. produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids. The company also offers veterinarian-formulated products, including tinctures, chews, and topicals under the Paw CBD brand name; nootropic mushroom line under the ATRx brand; and hemp derived solutions under the hempMD brand. It distributes its products through its e-commerce website, third-party e-commerce sites, select distributors and marketing partners, wholesalers, and various brick and mortar retailers in the United States. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. is headquartered in Charlotte, North Carolina.Read More… cbdMD Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks34th Percentile Overall ScoreYCBD MarketRank™: cbdMD scored higher than 34% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingcbdMD has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoveragecbdMD has only been the subject of 1 research reports in the past 90 days.Read more about cbdMD's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatiocbdMD has a P/B Ratio of 3.28. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about cbdMD's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted13.13% of the float of cbdMD has been sold short.Short Interest Ratio / Days to CovercbdMD has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in cbdMD has recently decreased by 83.31%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldcbdMD does not currently pay a dividend.Dividend GrowthcbdMD does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted13.13% of the float of cbdMD has been sold short.Short Interest Ratio / Days to CovercbdMD has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in cbdMD has recently decreased by 83.31%, indicating that investor sentiment is improving significantly. News and Social Media1.6 / 5News Sentiment-0.12 News SentimentcbdMD has a news sentiment score of -0.12. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.75 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 4 news articles for cbdMD this week, compared to 0 articles on an average week.Search InterestOnly 1 people have searched for YCBD on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows1 people have added cbdMD to their MarketBeat watchlist in the last 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, cbdMD insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.95% of the stock of cbdMD is held by insiders.Percentage Held by InstitutionsOnly 7.18% of the stock of cbdMD is held by institutions.Read more about cbdMD's insider trading history. Receive YCBD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for cbdMD and its competitors with MarketBeat's FREE daily newsletter. Email Address YCBD Stock News HeadlinescbdMD grants restricted stock units to directorsMay 21 at 7:58 PM | investing.comcbdMD, Inc. (AMEX:YCBD) Q2 2025 Earnings Call TranscriptMay 17, 2025 | msn.com[INSIDE] Elon’s Next Move Could Send This AI Stock SoaringMissed Nvidia? This Under-the-Radar AI Stock Could Be Next Musk's AI empire is just beginning — and one overlooked company could be at the center of it all. We reveal everything in this exclusive Memorial Day webinar.May 24, 2025 | Behind the Markets (Ad)cbdMD, Inc. (AMEX:YCBD) Q2 2025 Earnings Call TranscriptMay 17, 2025 | msn.comcbdMD Inc (YCBD) Q2 2025 Earnings Call Highlights: Strategic Moves and Financial Improvements ...May 17, 2025 | finance.yahoo.comcbdMD, Inc. (YCBD) Q2 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.com3YCBD : An Overview of cbdMD's EarningsMay 15, 2025 | benzinga.comcbdMD, Inc. to Host Conference Call to Discuss March 31, 2025, Second Quarter of Fiscal Year ...May 9, 2025 | gurufocus.comSee More Headlines YCBD Stock Analysis - Frequently Asked Questions How have YCBD shares performed this year? cbdMD's stock was trading at $2.6232 at the start of the year. Since then, YCBD stock has decreased by 64.9% and is now trading at $0.9197. View the best growth stocks for 2025 here. How were cbdMD's earnings last quarter? cbdMD, Inc. (NYSEAMERICAN:YCBD) released its quarterly earnings results on Thursday, December, 16th. The company reported ($25.20) EPS for the quarter, missing the consensus estimate of ($16.20) by $9.00. The company had revenue of $9.79 million for the quarter. cbdMD had a negative trailing twelve-month return on equity of 109.27% and a negative net margin of 13.67%. When did cbdMD's stock split? cbdMD shares reverse split on the morning of Wednesday, May 7th 2025. The 1-8 reverse split was announced on Monday, April 21st 2025. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, May 6th 2025. An investor that had 100 shares of stock prior to the reverse split would have 13 shares after the split. How do I buy shares of cbdMD? Shares of YCBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of cbdMD own? Based on aggregate information from My MarketBeat watchlists, some other companies that cbdMD investors own include Village Farms International (VFF), Tilray (TLRY), NVIDIA (NVDA), Roku (ROKU), Organigram (OGI), Bristol-Myers Squibb (BMY) and Bionano Genomics (BNGO). Company Calendar Last Earnings12/16/2021Today5/24/2025Next Earnings (Estimated)8/12/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorBusiness Services Industry Toilet preparations Sub-IndustryConsumer Goods Current SymbolNYSEAMERICAN:YCBD CIK1644903 Webwww.cbdmd.com Phone(704) 445-3060FaxN/AEmployees90Year FoundedN/APrice Target and Rating Average Stock Price Target$3.00 High Stock Price Target$3.00 Low Stock Price Target$3.00 Potential Upside/Downside+226.2%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,700,000.00 Net Margins-13.67% Pretax Margin-13.67% Return on Equity-109.27% Return on Assets-21.28% Debt Debt-to-Equity RatioN/A Current Ratio0.69 Quick Ratio0.46 Sales & Book Value Annual Sales$19.48 million Price / Sales0.30 Cash FlowN/A Price / Cash FlowN/A Book Value$0.28 per share Price / Book3.28Miscellaneous Outstanding Shares6,260,000Free Float6,204,000Market Cap$5.76 million OptionableNot Optionable Beta2.04 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NYSEAMERICAN:YCBD) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding cbdMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share cbdMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.